Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 13 February 2006. doi:10.1136/ard.2005.046920
Annals of the Rheumatic Diseases 2006;65:998-1005
Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism.

EXTENDED REPORT

Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac

M A Álvarez-Soria1,*, R Largo1,*, J Santillana2, O Sánchez-Pernaute1, E Calvo1, M Hernández2, J Egido1, G Herrero-Beaumont1

1 Joint and Bone Research Unit, Fundación Jiménez Díaz, Autonomous University, Madrid, Spain
2 Orthopaedic Surgery Department, Hospital Virgen de la Cinta, Tortosa, Tarragona, Spain

Correspondence to:
Dr G Herrero-Beaumont
Servicio de Reumatología, Fundación Jiménez Díaz Avenida Reyes Católicos 2, 28040 Madrid, Spain; gherrero{at}fjd.es

Objective: To compare the effect of celecoxib with that of a classic non-steroidal anti-inflammatory drug (NSAID) on synovial inflammation and on the synovial expression of proinflammatory genes in patients with knee osteoarthritis (OA).

Methods: 30 patients with severe knee OA scheduled for total knee replacement surgery were included in a 3 month clinical trial. They were randomised to two groups: patients treated with celecoxib (CBX) (200 mg/24 h) and patients treated with aceclofenac (ACF) (100 mg/12 h). Those patients with OA who did not want to be treated with NSAIDs served as a control group. During knee surgery, synovial fluid (SF) and synovial membrane (SM) were collected. A SM specimen was fixed and embedded in paraffin and another part was frozen for molecular biology studies.

Results: At the end of study both CBX and ACF treated patients showed a significant improvement in pain and knee function compared with controls. Both drugs significantly reduced prostaglandin E2 (PGE2) SF concentration and down regulated COX-2 mRNA and protein expression at the SM. However, synovial macrophage infiltration (CD68 antigen staining) and expression of proinflammatory mediators, such as interleukin 1ß and tumour necrosis factor {alpha}, were decreased only by CBX treatment.

Conclusion: Both drugs improved joint pain and function, inhibited SF PGE2 concentration, and induced a decrease in synovial COX-2 expression and synthesis not related to the tissue inflammatory status. These data suggest that PGE2 blocking agents may decrease PGE2 production not only by direct COX-2 inhibition but also by down regulating COX-2 expression and synthesis. However, CBX and ACF appear to have different anti-inflammatory profiles in controlling OA synovial macrophage infiltration and proinflammatory expression.

Abbreviations: ACF, aceclofenac; CBX, celecoxib; COX, cyclo-oxygenase; IL, interleukin; NSAIDs, non-steroidal anti-inflammatory drugs; OA, osteoarthritis; PCR, polymerase chain reaction; PG, prostaglandin; SF, synovial fluid; SM, synovial membrane; TNF, tumour necrosis factor; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index

Keywords: osteoarthritis; COX-2; synovial membrane; non-steroidal anti-inflammatory drugs; celecoxib


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Largo, R., Martinez-Calatrava, M. J., Sanchez-Pernaute, O., Marcos, M. E., Moreno-Rubio, J., Aparicio, C., Egido, J., Herrero-Beaumont, G. (2009). Effect of a high dose of glucosamine on systemic and tissue inflammation in an experimental model of atherosclerosis aggravated by chronic arthritis. Am. J. Physiol. Heart Circ. Physiol. 297: H268-H276 [Abstract] [Full Text]  
  • Alvarez-Soria, M. A., Herrero-Beaumont, G., Sanchez-Pernaute, O., Bellido, M., Largo, R. (2008). Diacerein has a weak effect on the catabolic pathway of human osteoarthritis synovial fibroblast--comparison to its effects on osteoarthritic chondrocytes. Rheumatology (Oxford) 47: 627-633 [Abstract] [Full Text]  
  • Khoromi, S., Muniyappa, R., Nackers, L., Gray, N., Baldwin, H., Wong, K. A., Matheny, L. A., Moquin, B., Rainer, A., Hill, S., Remaley, A., Johnson, L. L., Max, M. B., Blackman, M. R. (2006). Effects of Chronic Osteoarthritis Pain on Neuroendocrine Function in Men. J. Clin. Endocrinol. Metab. 91: 4313-4318 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs